On April 13th, Tianhong, an innovative drug ETF, had a net redemption of 8 million units, with a latest scale of 1.675 billion yuan, an increase of 39.71% in the past year

2026-04-14 15:22

Economic Observation Network On April 13th, Tianhong Innovative Medicine ETF had a net subscription of -8 million shares, accounting for 0.37% of the ETF fund shares. The latest shares of the fund are 2.162 billion, with a cumulative increase of 1.796 billion over the past three years. The latest scale is 1.675 billion yuan, with a cumulative increase of 1.419 billion yuan over the past three years.

The fund has risen 39.71% in the past year, with a maximum drawdown of 23.99%. The current ETF yield is -0.14%, exceeding the historical 27%, indicating a low-risk zone with a small deviation from net asset value and a high margin of safety.

The above content is based on publicly available information and does not constitute investment advice.

Disclaimer: The views expressed in this article are for reference and communication only and do not constitute any advice.